International Assets Investment Management LLC Takes $1.10 Million Position in DaVita Inc. (NYSE:DVA)

International Assets Investment Management LLC purchased a new position in shares of DaVita Inc. (NYSE:DVA) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 10,476 shares of the company’s stock, valued at approximately $1,097,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Vanguard Group Inc. boosted its position in DaVita by 1.1% during the third quarter. Vanguard Group Inc. now owns 6,175,029 shares of the company’s stock worth $583,725,000 after acquiring an additional 65,526 shares during the last quarter. Invesco Ltd. boosted its holdings in shares of DaVita by 21.3% during the 3rd quarter. Invesco Ltd. now owns 1,667,255 shares of the company’s stock worth $157,606,000 after purchasing an additional 292,767 shares during the last quarter. Deutsche Bank AG grew its position in shares of DaVita by 421.8% in the third quarter. Deutsche Bank AG now owns 1,095,081 shares of the company’s stock valued at $103,518,000 after purchasing an additional 885,195 shares in the last quarter. Lazard Asset Management LLC increased its holdings in shares of DaVita by 8.7% in the third quarter. Lazard Asset Management LLC now owns 845,416 shares of the company’s stock valued at $79,916,000 after purchasing an additional 67,970 shares during the last quarter. Finally, Northern Trust Corp lifted its position in DaVita by 15.7% during the third quarter. Northern Trust Corp now owns 834,608 shares of the company’s stock worth $78,895,000 after buying an additional 113,508 shares in the last quarter. 90.12% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of analysts have issued reports on the company. Barclays began coverage on DaVita in a research note on Wednesday, March 6th. They issued an “equal weight” rating and a $133.00 target price for the company. StockNews.com lowered shares of DaVita from a “strong-buy” rating to a “buy” rating in a report on Tuesday, April 16th. Truist Financial raised their price target on shares of DaVita from $130.00 to $135.00 and gave the stock a “hold” rating in a report on Tuesday, February 20th. TheStreet upgraded DaVita from a “c+” rating to a “b-” rating in a report on Wednesday, February 7th. Finally, UBS Group increased their price objective on DaVita from $113.00 to $134.00 and gave the stock a “buy” rating in a research report on Wednesday, February 14th. Two analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $118.50.

Insider Transactions at DaVita

In related news, insider James O. Hearty sold 26,164 shares of DaVita stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $119.64, for a total value of $3,130,260.96. Following the completion of the transaction, the insider now owns 20,264 shares in the company, valued at $2,424,384.96. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other DaVita news, CEO Javier Rodriguez sold 67,603 shares of the company’s stock in a transaction dated Monday, February 26th. The stock was sold at an average price of $126.11, for a total transaction of $8,525,414.33. Following the sale, the chief executive officer now owns 488,697 shares in the company, valued at approximately $61,629,578.67. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider James O. Hearty sold 26,164 shares of DaVita stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $119.64, for a total value of $3,130,260.96. Following the completion of the transaction, the insider now owns 20,264 shares of the company’s stock, valued at approximately $2,424,384.96. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 134,540 shares of company stock valued at $16,551,071. 1.40% of the stock is currently owned by corporate insiders.

DaVita Price Performance

Shares of DVA opened at $132.52 on Tuesday. The firm has a 50-day simple moving average of $131.04 and a two-hundred day simple moving average of $109.53. The company has a debt-to-equity ratio of 6.65, a current ratio of 1.19 and a quick ratio of 1.13. DaVita Inc. has a 1-year low of $71.51 and a 1-year high of $141.54. The stock has a market cap of $11.62 billion, a PE ratio of 17.91, a P/E/G ratio of 1.14 and a beta of 1.04.

DaVita (NYSE:DVA) last announced its earnings results on Tuesday, February 13th. The company reported $1.87 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.53 by $0.34. DaVita had a return on equity of 64.42% and a net margin of 5.70%. The company had revenue of $3.15 billion for the quarter, compared to analyst estimates of $3.01 billion. During the same quarter in the previous year, the company earned $1.11 earnings per share. The firm’s quarterly revenue was up 7.8% compared to the same quarter last year. As a group, analysts forecast that DaVita Inc. will post 9.23 EPS for the current year.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.